CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 22,100 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 22,600 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 70,000 shares (grant or award)
- 4 Grant or award EXEC. VP AND CLO acquired 21,200 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Planned sale CHIEF TECHNICAL OPS OFFICER sold 646 shares at $27.25 ($17,604)
- 4 Planned sale EXEC. VP AND CLO sold 794 shares at $27.25 ($21,637)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 366 shares at $27.25 ($9,974)
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 318 shares at $27.25 ($8,666)
- 4 Planned sale Director sold 10,000 shares at $27.38 ($273,804)
- 4 Planned sale SVP, FINANCE & CAO sold 2,841 shares at an average $28.86 ($81,986)
- 4 Planned sale Director sold 1,500 shares at $27.81 ($41,715)
- 4 Planned sale CHIEF BUSINESS OFFICER sold 3,634 shares at an average $28.85 ($104,852)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 7,680 shares at an average $28.91 ($221,996)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,000 shares at an average $28.87 ($57,739)
Page 9 of 31 · 618 filings